The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, ...

Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics ...

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys ...

Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.

Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding ...

The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after ...

Evidence generation is a strategic imperative in medtech, driving revenue, market access, and long-term business growth. Yet, ...

Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources ...